AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06637774 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Videofluoroscopic X-ray
Description: MBS is a fluoroscopic diagnostic test to evaluate swallowing physiology. Its images are judged by humans trained to do so.
Study NCT06639048 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: Questionnaire including demographic characteristics, social media usage habits, body weight, height, effects of social media on eating behavior scale and eating disorder fear questionnaire.
Study NCT05812690 — intervention group
Intervention type: OTHER
Intervention: This is a non intervention - observation only study
Description: This is non intervention study
Study NCT06640647 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HDM1005 injection or placebo
Description: HDM1005 injection or placebo isubcutaneous injection once
Study NCT05583565 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sensory integration approach
Description: Sensory integration refers to how the nervous system receives messages from multimodal sensory information systems to maintain balance, posture, and balance by monitoring head movement and stabilizing the eyes about the environment
Study NCT05583565 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: traditional physical therapy program
Description: conventional physiotherapy training programs such as the following: 1)Hand function training by locating the Grading of the hand and training this level until it is well developed to transfer to the next level according to 8 parameters (partner's height-shape-weight-texture -reaction time-speed-accuracy-number of trials).~2) equilibrium training by promoting posture reaction. 3)ADL activity training (nutrition training-dressing training-toilet training). 4) Functional skill training through walking (walking on sand, weight on legs, and Climbing stairs ).
Study NCT06382831 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Opioid free anesthesia
Study NCT06382831 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl
Description: Control given Opioid balanced anesthesia
Study NCT05454501 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Training
Description: For eight weeks, they will receive real-time online exercise training for 30 minutes, three days a week, with a peer group of 5-6 people. Before starting the exercise, physical activity will be monitored for seven days.
Study NCT05454501 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient Education
Description: After the first face-to-face evaluation session, these patients and their families will receive a 1-hour patient education program specific to the disease and exercise. Information brochures containing physical activity and exercise recommendations will be given. They will be followed up with weekly phone calls throughout the study period. At the end of 8 weeks, the second evaluation interview will be held. Afterward, the patients in the control group will be able to participate in the online exercise training program if they request it.
Study NCT05534685 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intratracheal administration of surfactant/budesonide
Description: 328 patients will be included from Group A: 164 patients, from Group B: 164 patients who meet the selection criteria within the first 4 hours of hospital stay, after the authorization of the parents or guardian signing the informed consent. According to the assigned group, the preparation of surfactant or surfactant/budesonide in the syringe will be carried out, prior to performing the tracheal cannulation procedure. Group A will be given surfactant (beractant, lung phospholipids of bovine origin. Injectable suspension 1ml contains 25mg) at a dose of 100mg/kg or 4ml/kg and budesonide (budesonide, nebulized suspension 2ml contains 0.500mg) at a dose of 0.250 mg/kg or 1 ml/kg. Group B will receive surfactant alone (beractant, lung phospholipids of bovine origin. Injectable suspension 1ml contains 25mg) administered at a dose of 100mg/kg or 4ml/kg.
Study NCT05534685 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: incidence of bronchopulmonary dysplasia
Description: . Subsequently, follow-up will be carried out at 12 hours to assess the administration of the second dose of surfactant, type of mechanical ventilation, inspired fraction of oxygen (Fi02), arterial pressure of oxygen (PaO2), partial pressure of carbon dioxide (PaCO2 ), mean airway pressure (PMVA), oxygen index (IO), oxygen saturation by pulse oximetry, weekly follow-up of the patient will continue for 28 days, evaluating the same parameters to make a diagnosis of bronchopulmonary dysplasia and finally at 36 postmenstrual weeks of gestation in those under 32 SDG or at discharge and at 56 postmenstrual days of life in those over 32 SDG or at discharge, allowing the severity of the disease to be determined
Study NCT06558474 — intervention group
Intervention type: BEHAVIORAL
Intervention: Liberal post-dilatation strategy during PCI
Description: A liberal post-dilatation strategy for stent optimization during PCI will be implemented in multiple centers in the Netherlands.~This include an increase of post-dilatation use of at least 20% per operator, or a percentage of post-dilatation of at least 85%.~Operators will be asked to enforce a very low threshold for post-dilatation in general, with a mandatory HPNC post-dilatation for the following indications:~* In case of any calcification~* Delta of ≥ 0.5mm between the distal and proximal reference diameter of the treated coronary segment~* Stent length >24 mm~* Signs of incomplete stentframe-deployment on angiography or StentBoost~* In case of CTO~* In case of bifurcation PCI (Left main and non-left main)~  * Proximal Optimisation Technique (POT) with NC balloon~ * Final Kissing Balloon dilatation (FKB) with preferentially first sequential high-pressure inflations and final low pressure kiss both with NC balloons
Study NCT05089279 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D113
Description: QD, PO
Study NCT05089279 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-349
Description: QD, PO
Study NCT06157255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD4604 Inhalation Powder, 1 mg
Description: 3 mg dose, inhaled, fasted
Study NCT06157255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]AZD4604 Solution for Infusion 6 μg/mL (NMT 37.0 kBq/5 mL)
Description: 30 μg, intravenous, fasted
Study NCT06157255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]AZD4604 Oral Solution, 4 mg (NMT 37.0 kBq)
Description: 4 mg, oral, fasted
Study NCT05824988 — intervention group
Intervention type: OTHER
Intervention: Drug exposure
Description: Drug concentrations will be measured after one-month antimycobacterial treatment. Area under drug concentration-time curve (AUC) and maximum concentration (Cmax) will be calculated.
Study NCT05890339 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic Proximal Gastrectomy With Double-flap Technique
Description: Patients in this group receive laparoscopic proximal gastrectomy with D1+/D2 lymph node dissection(D1+ for stage IA：Nos.1, 2, 3a, 4 sa, 4 sb, 7, 8a, 9, 11p；D2 for stage IB: Nos.1, 2, 3a, 4 sa, 4 sb, 7, 8a, 9, 11p and 11d). The double-flap technique is used for the esophagogastric reconstruction.
Study NCT05890339 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic Total Gastrectomy With Roux-en-Y Reconstruction
Description: Patients in this group receive laparoscopic total gastrectomy with D1+/D2 lymph node dissection(D1+ for stage IA：Nos.1, 2, 3, 4, 5, 6, 7, 8a, 9, 11p；D2 for stage IB: Nos.1, 2, 3, 4, 5, 6, 7, 8a, 9, 11p and 11d, 12a). The Roux-en-Y esophagojejunostomy method is used for the esophagojejunal reconstruction.
Study NCT06112704 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-20093
Description: Intravenous (IV) infusion of HS-20093 Q3W; Participants will receive continuous treatment until the end of the study in the absence of unacceptable toxicities and confirmed disease progression.
Study NCT06645249 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amiodarone (Antiarrhythmic drug)
Description: Comparing 2 regimes of amiodarone pre-electrical cardioversion witn ECG monitoring
Study NCT06645249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amiodarone (Antiarrhythmic drug)
Description: Comparing 2 regimes of amiodarone pre-electrical cardioversion witn ECG monitoring
Study NCT04873908 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: modified constraint-induced therapy
Description: Patients received conventional rehabilitation and modified constraint-induced therapy schedule
Study NCT04873908 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Proprioceptive Training
Description: Patients received conventional rehabilitation and Proprioceptive Training schedule
Study NCT04873908 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: conventional rehabilitation
Description: Patients received conventional rehabilitation schedule
Study NCT06176586 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mat Pilates Exercises
Description: The intervention will consist of mat Pilates exercises performed twice a week over a duration of 12 weeks, as an adjunct to the routine medical treatment for the patients, under the guidance of a qualified physiotherapist. Each exercise session will last for approximately 60 minutes. The treatment protocol will encompass targeted mobility exercises for the thoracic and lumbar regions, along with strengthening exercises focusing on core activation. The exercise program will be progressed in every four weeks.
Study NCT05220202 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Intervention Group (MOTIVATE)
Description: Behavioral: Behavioral Intervention Group (MOTIVATE) The behavioral intervention is designed for older Veterans with musculoskeletal pain and depression and will include 8 individual telephone sessions delivered by health coaches (for up to 5 months total), accounting for additional time between sessions (if needed).
Study NCT06540976 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive testing
Description: Cognitive tasks testing executive and episodic based decisions, and the switching between these processes.
Study NCT06119321 — intervention group
Intervention type: OTHER
Intervention: Pentacam, Corvis ST and Scansys
Description: morphological and biomechanical parameters of corneal were obtain by Scansys, Pentacam and Corvis ST
Study NCT04724252 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gabapentin
Description: Determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after surgery.
Study NCT04724252 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Control Arm
Study NCT04770285 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: CT-152 - Digital Therapeutic
Description: CT-152 mobile app was used by the participants as per the schedule specified in the respective arm.
Study NCT04770285 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Sham
Description: Sham mobile app was used by the participants as per the schedule specified in the respective arm.
Study NCT06183567 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sedoanalgesia
Description: In Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy, the procedure was performed under sedoanalgesia. The procedure was continued with mean arterial pressure, heart rate, pulse oximetry and BIS monitoring.
Study NCT06183567 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: general anesthesia
Description: In Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy, the procedure was performed under general anesthesia. The procedure was continued with mean arterial pressure, heart rate, pulse oximetry and BIS monitoring.
Study NCT06539728 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Interaction with Mock COVID-19 Rapid Antigen Test and Reference Surfaces
Description: Participants will drop a saline solution with proteins onto the testing device. They will wait for it to dry and then report on the tactile sensation and overall feel of the surface. Feedback will include comparisons with the two reference surfaces. The primary goal is to determine the presence of mock COVID antigen in synthetic saliva using the device, which aligns with the goals of diagnostic testing.
Study NCT06539728 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Biomechanical Measurements
Description: Participants may have biomechanical measurements recorded, such as placing samples on a scale to measure downward force or using medical tape with a flexible wire to track finger motion. These measurements are likely aimed at objectively assessing how participants interact with the surfaces and their physical responses to tactile stimuli.
Study NCT06539728 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychophysical Tasks
Description: Participants may alternatively be asked to perform standardized psychophysical tasks, such as Two Alternative Forced Choice tests, Odd-Man Out tests, or Magnitude Estimation tests. These tasks will provide structured comparisons and quantitative data on participants' perception and preferences regarding tactile qualities. The tasks are designed to evaluate participants' perception and preferences regarding tactile qualities, which involves behavioral responses to sensory stimuli.
Study NCT04458766 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Monetary incentives
Description: This intervention will assess the efficacy of subjects using the Wellth mobile phone application to provide reminders to take their statin medication, and receiving monetary incentives for taking their medication as prescribed.
Study NCT06637748 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Echocardiography
Description: Transthoracic echocardiography~• Parameters assessed:~* Right ventricular dimensions and function~* Pulmonary artery pressure estimation~* Valvular function assessment~* Left ventricular dimensions (end-diastolic and end-systolic)o Left ventricular function (ejection fraction, fractional shortening)
Study NCT06637748 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Electrocardiography
Description: Standard 12-lead ECG recording~• Parameters assessed:~* Heart rate and rhythm~* P-wave morphology~* PR interval~* QRS complex duration and morphology~* ST-segment changes~* T-wave abnormalities~* QT interval
Study NCT06636955 — intervention group
Intervention type: OTHER
Intervention: biobank
Description: * nasopharyngeal swab collection~* nasopharyngeal nasal washes collection, during hospitalization, if any
Study NCT06636955 — intervention group
Intervention type: OTHER
Intervention: follow up
Description: - one year follow up: after 1 month, 3 months, 6 months et 12 months
Study NCT06640127 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sinus lifting and implant placement with osteotomes
Description: Osteotomes with increasing diameters were used for sinus membrane elevation and implant insertion
Study NCT06640127 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sinus lifting and implant placement with specifically designed drills
Description: Sequential drills were used for sinus membrane elevation and implant insertion
Study NCT06638034 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-FAPI-RGD for PET / CT scan and 177Lu-FAPI-RGD for therapy
Description: Patients with positive results were screened with 68Ga-FAPI PET / CT, and 2.22-3.33GBq(60mci-100mCi) 177Lu-FAPI-RGD was injected intravenously for therapy after contraindications were excluded and informed consent was signed.
Study NCT06640270 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diabetes Treatment
Description: Lucie™ is an innovative medical device for measurement by bio-impedancemetry. It has been developed specifically to meet medical needs in nephrology. The aim of the study is to compare its performance with a reference device validated in nephrology nephrology, the Body Composition Monitor® (BCM) from Fresenius.
Study NCT05598528 — intervention group
Intervention type: OTHER
Intervention: Genomic profiles detection
Description: The Paraffin-embedded tumor tissue at diagnosis is collected and assessed by Next- generation gene sequencing
Study NCT05598528 — intervention group
Intervention type: OTHER
Intervention: circulating tumor DNA detection
Description: The Plasma at diagnosis and at 1-month treatment are collected and assessed by Next-generation gene sequencing
Study NCT05512390 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABBV-319
Description: Intravenous (IV); Infusion
Study NCT06287736 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal Cord Stimulator Implantation (SCS)
Description: Spinal cord stimulator implantation is broken up into two parts. The first part involves placement of temporary SCS leads for a one-week trial. If the participants respond favorably to the SCS, then they will undergo the second part and the device is implanted
Study NCT06628973 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social prescribing
Description: The intervention consists of SP, wherein patients identified as having significant SDOH-related vulnerabilities on the SPARK questionnaire or during an interview will have a consultation with a LW who will provide them with social prescriptions. LWs are individuals who LINK individuals with social needs to existing community supports and services within the community
Study NCT06489249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral placebo tablet
Study NCT06489249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salsalate 750 MG Oral Tablet [DISALCID]
Description: Oral salsalate tablet
Study NCT05947058 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroplasty
Description: The type of hip prothesis (hemi or total; cemented or uncemented) will be at the discretion of the treating surgeon.
Study NCT05947058 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Internal Fixation
Description: Both fixed angle devices and multiple screws will be permitted for the internal fixation group.
Study NCT06181396 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Oxytocin
Description: Native oxytocin analog
Study NCT06181396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin
Description: Native oxytocin analog
Study NCT06641583 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LEGO
Description: The LEGO Therapy intervention in this clinical trial is designed to enhance social skills in children with high-functioning Autism Spectrum Disorder (ASD). The intervention involves the following components:~Group Sessions: The therapy will be conducted in small groups of three children of the same age (10-14 years) with a diagnosis of high-functioning ASD. The sessions are designed to foster collaboration and social interaction between the participants.~Duration: The intervention will last for 3 months, consisting of 12 sessions, with each session lasting 90 minutes. Sessions will take place once a week at the IRCCS Fondazione Stella Maris.~Supervision: The groups will be supervised by trained professionals specializing in neurodevelopmental disorders, ensuring that the therapy is structured and supportive of each child\&amp;amp;amp;#39;s individual needs.~Therapy Structure: During the sessions, children will engage in LEGO-based tasks, where they collaborate to build LEGO models.
Study NCT06641583 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Controllo
Description: This group will also consist of children aged 10-14 diagnosed with high-functioning ASD. However, these children will not receive LEGO therapy. Instead, they will continue their usual treatments in their local settings without participating in the LEGO therapy sessions. This group\&#39;s outcomes will be compared with the experimental group to assess the effectiveness of LEGO therapy.
Study NCT05998993 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy SBRT
Description: This is a non-randomized Phase II study in which all patients receive the experimental treatment with Stereotactic Ablative Radiotherapy (SABR) to residual tumor lesions (up to 5 residual metastatic lesions in a maximum of 2 organs) following 12 weeks of systemic treatment with Osimertinib. The study aims to enroll 35 patients diagnosed and treated at CTIC Centro de Tratamiento e Investigación Sobre Cáncer Luis Carlos Sarmiento Angulo.
Study NCT06640153 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: mpMRI
Description: Gastroesophageal junction or upper gastric adenocarcinoma patients undergo mpMRI at siewert classification, length of esophageal involvement, primary staging and restaging
Study NCT06643429 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: colorectal cancer
Description: Patients diagnosed with colorectal cancer by pathological biopsy.
Study NCT06643429 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: colorectal neoplasm
Description: Patients diagnosed with colorectal adenoma confirmed by colonoscopy.
Study NCT05935150 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Omit SLNB
Description: All patients enrolled have to receive two or more imaging tests including axillary ultrasound assessed as axillary lymph node negative, and other tests including MRI, PET-CT, \[18F\]-FDG PET-MRI, axillary surgery will be omitted for eligible patients, and BCS or mastectomy (allowing breast reconstruction) will be chosen voluntarily by the patient under the premise of ensuring therapeutic efficacy, patients receiving BCS must undergo whole breast irradiation (WBI) after surgery, and the radiotherapy target area does not include the axillary region.